Author
Listed:
- Jeff Ondocsin
(Center for AIDS Prevention Studies, Department of Medicine, University of California, San Francisco, CA 94143, USA
Family & Community Medicine, Department of Medicine, University of California, San Francisco, CA 94143, USA)
- Daniel Ciccarone
(Family & Community Medicine, Department of Medicine, University of California, San Francisco, CA 94143, USA)
- Lissa Moran
(Center for AIDS Prevention Studies, Department of Medicine, University of California, San Francisco, CA 94143, USA)
- Simon Outram
(Center for AIDS Prevention Studies, Department of Medicine, University of California, San Francisco, CA 94143, USA)
- Dan Werb
(Centre on Drug Policy Evaluation, St. Michael’s Hospital, Toronto, ON M5B 1W8, Canada
Division of Infectious Diseases & Global Public Health, UC San Diego School of Medicine, University of California, San Diego, CA 92093, USA)
- Laura Thomas
(San Francisco AIDS Foundation, San Francisco, CA 94103, USA)
- Emily A. Arnold
(Center for AIDS Prevention Studies, Department of Medicine, University of California, San Francisco, CA 94143, USA
Family & Community Medicine, Department of Medicine, University of California, San Francisco, CA 94143, USA)
Abstract
The year 2021 was the most deadly year for overdose deaths in the USA and Canada. The stress and social isolation stemming from the COVID-19 pandemic coupled with a flood of fentanyl into local drug markets created conditions in which people who use drugs were more susceptible to accidental overdose. Within territorial, state, and local policy communities, there have been longstanding efforts to reduce morbidity and mortality within this population; however, the current overdose crisis clearly indicates an urgent need for additional, easily accessible, and innovative services. Street-based drug testing programs allow individuals to learn the composition of their substances prior to use, averting unintended overdoses while also creating low threshold opportunities for individuals to connect to other harm reduction services, including substance use treatment programs. We sought to capture perspectives from service providers to document best practices around fielding community-based drug testing programs, including optimizing their position within a constellation of other harm reduction services to best serve local communities. We conducted 11 in-depth interviews from June to November 2022 via Zoom with harm reduction service providers to explore barriers and facilitators around the implementation of drug checking programs, the potential for integration with other health promotion services, and best practices for sustaining these programs, taking the local community and policy landscape into account. Interviews lasted 45–60 min and were recorded and transcribed. Thematic analysis was used to reduce the data, and transcripts were discussed by a team of trained analysts. Several key themes emerged from our interviews: (1) the instability of drug markets amid an inconsistent and dangerous drug supply; (2) implementing drug checking services in dynamic environments in response to the rapidly changing needs of local communities; (3) training and ongoing capacity building needed to create sustainable programs; and (4) the potential for integrating drug checking programs into other services. There are opportunities for this service to make a difference in overdose deaths as the contours of the drug market itself have changed over time, but a number of challenges remain to implement them effectively and sustain the service over time. Drug checking itself represents a paradox within the larger policy context, putting the sustainability of these programs at risk and challenging the potential to scale these programs as the overdose epidemic worsens.
Suggested Citation
Jeff Ondocsin & Daniel Ciccarone & Lissa Moran & Simon Outram & Dan Werb & Laura Thomas & Emily A. Arnold, 2023.
"Insights from Drug Checking Programs: Practicing Bootstrap Public Health Whilst Tailoring to Local Drug User Needs,"
IJERPH, MDPI, vol. 20(11), pages 1-19, May.
Handle:
RePEc:gam:jijerp:v:20:y:2023:i:11:p:5999-:d:1159538
Download full text from publisher
References listed on IDEAS
- Wendy Masterton & Danilo Falzon & Gillian Burton & Hannah Carver & Bruce Wallace & Elizabeth V. Aston & Harry Sumnall & Fiona Measham & Rosalind Gittins & Vicki Craik & Joe Schofield & Simon Little & , 2022.
"A Realist Review of How Community-Based Drug Checking Services Could Be Designed and Implemented to Promote Engagement of People Who Use Drugs,"
IJERPH, MDPI, vol. 19(19), pages 1-25, September.
- repec:cup:buetqu:v:29:y:2019:i:02:p:167-168_00 is not listed on IDEAS
- Rebecca S. Bolinski & Suzan Walters & Elizabeth Salisbury-Afshar & Lawrence J. Ouellet & Wiley D. Jenkins & Ellen Almirol & Brent Van Ham & Scott Fletcher & Christian Johnson & John A. Schneider & Dan, 2022.
"The Impact of the COVID-19 Pandemic on Drug Use Behaviors, Fentanyl Exposure, and Harm Reduction Service Support among People Who Use Drugs in Rural Settings,"
IJERPH, MDPI, vol. 19(4), pages 1-12, February.
- repec:cup:buetqu:v:29:y:2019:i:04:p:435-436_00 is not listed on IDEAS
Full references (including those not matched with items on IDEAS)
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.
- Jayme E. Walters & Aubrey E. Jones & Aaron R. Brown & Dorothy Wallis, 2022.
"Impacts of the COVID-19 Pandemic on a Rural Opioid Support Services Program,"
IJERPH, MDPI, vol. 19(18), pages 1-12, September.
- Anthony Mullin & Mark Scott & Giorgia Vaccaro & Rosalind Gittins & Salvatore Ferla & Fabrizio Schifano & Amira Guirguis, 2023.
"Handheld Raman Spectroscopy in the First UK Home Office Licensed Pharmacist-Led Community Drug Checking Service,"
IJERPH, MDPI, vol. 20(6), pages 1-27, March.
- Ahmed Al-Imam & Marek A. Motyka & Zuzanna Witulska & Manal Younus & Michał Michalak, 2022.
"Spatiotemporal Mapping of Online Interest in Cannabis and Popular Psychedelics before and during the COVID-19 Pandemic in Poland,"
IJERPH, MDPI, vol. 19(11), pages 1-17, May.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:20:y:2023:i:11:p:5999-:d:1159538. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.